問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
高憲立
下載
2025-08-01 - 2031-03-31
Condition/Disease
Test Drug
Participate Sites8Sites
Recruiting8Sites
2025-09-30 - 2032-03-31
Participate Sites11Sites
Recruiting11Sites
2026-02-01 - 2029-02-28
Participate Sites4Sites
Recruiting4Sites
2025-07-01 - 2028-05-31
Participate Sites5Sites
Recruiting5Sites
2025-10-01 - 2030-06-30
Participate Sites13Sites
Recruiting13Sites
2018-07-01 - 2035-06-30
-
Participate Sites1Sites
Recruiting1Sites
2020-06-11 - 2022-11-02
Participate Sites2Sites
Recruiting2Sites
2018-10-24 - 2024-03-31
Obesity
Semaglutide B 3.0 mg/mL PDS290 or Semaglutide placebo
Participate Sites6Sites
Terminated2Sites
Division of Cardiovascular Diseases
2021-09-01 - 2022-11-30
Participate Sites12Sites
Recruiting10Sites
全部
